The decision comes as Schumer is now the Senate’s #2 recipient of pharmaceutical industry campaign cash.
By David Sirota, The Lever
Senate Majority Leader Chuck Schumer (D-N.Y.) let a U.S. Senate adviser kill key parts of Democrats’ promised drug pricing legislation, as Schumer has become the Senate’s second largest recipient of pharmaceutical industry cash.
On Saturday, the Senate’s parliamentary adviser Elizabeth MacDonough — who Schumer can remove — issued a non-binding advisory opinion saying Democrats should remove provisions in their spending bill that would punish drugmakers for inflating their prices for patients in private health insurance plans. The provision could have saved $40 billion, according to one estimate.
“The exclusion of the private insurance price limits means there is little left that will reduce costs for the vast majority of Americans who receive health insurance through their private sector employer,” reported Politico.
MacDonough also advised Democrats against including a provision in their legislation to cap out-of-pocket insulin costs at $35 a month for people on private insurance plans. Democrats ultimately held a failed vote to overrule her on the insulin cap.
Recent Posts
How The Supreme Court Could Finally Force Big Oil To Face Trial
Take Action Now Dozens of cities and states sued oil giants for deceiving the public. The Supreme Court could soon break these cases out of limbo.…
Bill Fletcher: Keep Fighting Till The Lights Go Out
Take Action Now A conversation that touches on internationalism, the expanding political role of Black immigrants, and the need for building…
Iran Blames Israel For Last Week’s Attack On Isfahan Military Site
Take Action Now Iran asserted its right to defend itself after the failed drone strikes at the military workshop complex in Isfahan late on Saturday…
Majid Khan Released from Guantánamo After 16 Years
Take Action Now Mr. Khan is only the sixth man transferred by the Biden administration and the first resettled in a third country. His transfer marks…